The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia.

作者: İ. Orsel , S.D. , Akdemir , A. , Dağ

DOI: 10.1016/J.COMPPSYCH.2003.09.006

关键词:

摘要: We aimed to investigate the reliability and clinical sensitivity of World Health Organization Quality Life (WHOQOL-100) scale for patients diagnosed with schizophrenia because its multilingual, multidimensional, cross-cultural properties. Fifty-four stabilized outpatients 49 age-, sex-, occupation-matched healthy control subjects were recruited. The showed high internal consistency (Cronbach alpha = 0.94). While there was no correlation between total scores psychopathology measures (Brief Psychiatric Rating Scale [BPRS], assessment Negative Symptoms [SANS], Assessment Positive [SAPS], Clinical Global Impression [CGI]), significant negative correlations obtained especially subscales BPRS, SANS, SAPS, QOL domains. Stepwise multiple regression analysis also revealed that BPRS anxiety/depression SANS anhedonia subcales predictor variables in five six domains group. better quality-of-life mild group on physical psychological indicate WHOQOL-100 could be used as an outcome measure studies. Thus, is a reliable, subjective schizophrenia. should assessed large follow-up

参考文章(31)
G Tomlinson, S Packer, S Cohen, J Husted, Psychopathology and quality of life in schizophrenia. Journal of Psychiatry & Neuroscience. ,vol. 22, pp. 231- 234 ,(1997)
S.K. Min, K.I. Kim, C.I. Lee, Y.C. Jung, S.Y. Suh, D.K. Kim, Development of the Korean versions of WHO Quality of Life scale and WHOQOL-BREF. Quality of Life Research. ,vol. 11, pp. 593- 600 ,(2002) , 10.1023/A:1016351406336
L. N. P. Voruganti, R. J. Heslegrave, A. G. Awad, Quality of life measurement during antipsychotic drug therapy of schizophrenia. Journal of Psychiatry & Neuroscience. ,vol. 22, pp. 267- 274 ,(1997)
Suzanne M. Skevington, Advancing cross-cultural research on quality of life: Observations drawn from the WHOQOL development Quality of Life Research. ,vol. 11, pp. 135- 144 ,(2002) , 10.1023/A:1015013312456
Dennis A. Revicki, Laura A. Genduso, Susan H. Hamilton, Dara Ganoczy, Charles M. Beasley, Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial. Quality of Life Research. ,vol. 8, pp. 417- 426 ,(1999) , 10.1023/A:1008958925848
L. N. P. Voruganti, R. J. Heslegrave, A. G. Awad, The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia Journal of Psychiatry & Neuroscience. ,vol. 22, pp. 235- 243 ,(1997)
P. B. Fitzgerald, C. L. Williams, N. Corteling, S. L. Filia, K. Brewer, A. Adams, A. R. A. de Castella, T. Rolfe, P. Davey, J. Kulkarni, Subject and observer-rated quality of life in schizophrenia. Acta Psychiatrica Scandinavica. ,vol. 103, pp. 387- 392 ,(2001) , 10.1034/J.1600-0447.2001.00254.X
B. Carpiniello, G. Lai, C. M. Pariante, M. G. Carta, N. Rudas, Symptoms, standards of living and subjective quality of life: a comparative study of schizophrenic and depressed out-patients. Acta Psychiatrica Scandinavica. ,vol. 96, pp. 235- 241 ,(1997) , 10.1111/J.1600-0447.1997.TB10157.X